Calendar

Date TBD

ACTIVE_NOT_RECRUITINGphase readoutNCT05262426: Developing mHealth to Promote PrEP Use Among Thai Young Vulnerable Adolescents and Emerging Adults

Sponsor: University of Massachusetts, Worcester. Phase: NA. Conditions: Pre-Exposure Prophylaxis

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07654348: Efficacy and Mechanism of IPSRT for Bipolar II Disorder

Sponsor: First Affiliated Hospital of Zhejiang University. Phase: PHASE2. Conditions: Bipolar Disorder II

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT02942355: Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer

Sponsor: Wake Forest University Health Sciences. Phase: PHASE2. Conditions: Female Breast Carcinoma, Breast Cancer

full page →ctgov ↗

RECRUITINGphase readoutNCT06588855: A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Moderately to Severely Active Ulcerative Colitis

full page →ctgov ↗

RECRUITINGphase readoutNCT07554755: TIS for NSSI in Adolescent Depression

Sponsor: The Second Hospital of Anhui Medical University. Phase: NA. Conditions: Temporal Interference Stimulation, Non Suicidal Self Injury, Major Depressive Disorder

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07540078: Leveraging Large Language Models (LLM) to Enhance Research Competency Among Undergraduate Nursing Students: A Novel Approach to Research Education

Sponsor: National University Health System, Singapore. Phase: NA. Conditions: Education, AI (Artificial Intelligence)

full page →ctgov ↗

RECRUITINGphase readoutNCT07583485: GIM27-THERapy: a Study to Describe the Effectiveness of Tucatinib in Combination With Capecitabine and Trastuzumab in the Treatment of Metastatic HER-2 Positive Breast Cancer Patients in Real World Setting

Sponsor: Fondazione Oncotech. Phase: . Conditions: Breast Cancer

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT06539338: A Study to Investigate Safety of INT2104 Infusions in Participants Aged 18 Years of Age and Older Who Have B-cell Cancers That Came Back After Previous Treatment

Sponsor: Kite, A Gilead Company. Phase: PHASE1. Conditions: Lymphomas Non-Hodgkin's B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

full page →ctgov ↗

COMPLETEDphase readoutNCT03600155: Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia

full page →ctgov ↗

RECRUITINGphase readoutNCT06423326: Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Sponsor: Emory University. Phase: PHASE2. Conditions: Borderline Resectable Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage I Pancreatic Cancer AJCC v8, Stage II Pancreatic Cancer AJCC v8, Stage III Pancreatic Cancer AJCC v8

full page →ctgov ↗

RECRUITINGphase readoutNCT07530978: ORAL HYGIENE, PERIODONTAL STATUS AND QUALITY OF LIFE

Sponsor: Abant Izzet Baysal University. Phase: . Conditions: Periodontal Diseases, Gingivitis, Periodontitis

full page →ctgov ↗

RECRUITINGphase readoutNCT07379138: Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients

Sponsor: Mayo Clinic. Phase: NA. Conditions: Melanoma

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT06475248: Influence of Osteopathic Intervention on Cervical Muscles in Tension Headaches in Women

Sponsor: Escola Superior de Tecnologia da Saúde do Porto. Phase: NA. Conditions: Tension Headaches

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT00884455: Alpha-1 Foundation DNA and Tissue Bank

Sponsor: University of Florida. Phase: . Conditions: Alpha 1 Antitrypsin Deficiency

full page →ctgov ↗

RECRUITINGphase readoutNCT06728826: Prevention of Atrial Fibrillation After Cardiac Surgery by Pericardiotomy

Sponsor: Changhai Hospital. Phase: NA. Conditions: Atrial Fibrillation (AF), Cardiac Events, Pericardial Effusion

full page →ctgov ↗

WITHDRAWNphase readoutNCT06713226: Clinical Performance Evaluation of the Hativ P30

Sponsor: VUNO Inc.. Phase: NA. Conditions: Arrhythmia

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT07714226: A Multifaceted Assessment of Eating Behaviors, Anthropometric Measurements and Body Composition in Pediatric Patients With Drug-resistant Epilepsy on a Ketogenic Diet and Healthy Children

Sponsor: Wroclaw Medical University. Phase: . Conditions: Epilepsy Intractable

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07417878: Study of the Nutritional, Inflammatory, and Metabolic Endophenotypes of Attention-Deficit/Hyperactivity Disorder (ADHD)

Sponsor: University Hospital, Montpellier. Phase: NA. Conditions: ADHD - Attention Deficit Disorder With Hyperactivity

full page →ctgov ↗

RECRUITINGphase readoutNCT06657378: A Study to Evaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic Seizures

Sponsor: Eisai Co., Ltd.. Phase: . Conditions: Partial-Onset Seizures, Primary Generalized Tonic-clonic Seizures

full page →ctgov ↗

RECRUITINGphase readoutNCT07512778: IVUS-Guided vs Angiography-Guided PCI in Acute Coronary Syndrome

Sponsor: SUK MIN SEO. Phase: NA. Conditions: Acute Coronary Syndromes (ACS)

full page →ctgov ↗

RECRUITINGphase readoutNCT06561048: Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma

Sponsor: Corvus Pharmaceuticals, Inc.. Phase: PHASE3. Conditions: Peripheral T-Cell Lymphoma, Not Otherwise Specified, Angioimmunoblastic T-cell Lymphoma, Follicular T-Cell Lymphoma, Nodal Peripheral T-Cell Lymphoma With TFH Phenotype, Systemic Anaplastic Large Cell Lymphoma, Lymphoma, T-Cell, Peripheral, Lymphoma, T-Cell

full page →ctgov ↗

RECRUITINGphase readoutNCT05501678: Trial of Diphenhydramine for Sleep in Children With Autism

Sponsor: Stanford University. Phase: PHASE2. Conditions: Autism, Autism Spectrum Disorder

full page →ctgov ↗

COMPLETEDphase readoutNCT07666659: The Effects of Stabilization Exercises and Taping on Cervical Muscle Strength, Endurance, and Function in Women With Forward Head Posture.

Sponsor: Muğla Sıtkı Koçman University. Phase: NA. Conditions: Forward Head Posture

full page →ctgov ↗

RECRUITINGphase readoutNCT06054880: Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency

Sponsor: Prove pharm. Phase: PHASE4. Conditions: Ureter Injury

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07406880: Positive Psychology - Based EMl for Enhancing Well-Being

Sponsor: The Hong Kong Polytechnic University. Phase: NA. Conditions: Healthy Participants Study

full page →ctgov ↗

COMPLETEDphase readoutNCT07429279: Correlation Between Hip Mobility and Thoracic Flexion in Patients With Non-Specific Low Back Pain

Sponsor: Deraya University. Phase: . Conditions: Non-specific Low Back Pain, Low Back Pain, Musculoskeletal Disorders, Thoracic Spine Dysfunction

full page →ctgov ↗

RECRUITINGphase readoutNCT07546279: The Use of Two Bone Substitutes in Adjunct to EMD for the Treatment of One- and Two-wall Intrabony Defects.

Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio. Phase: NA. Conditions: Periodontitis, Bone Defects

full page →ctgov ↗

RECRUITINGphase readoutNCT07091279: Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism

Sponsor: Jeremy Veenstra-vanderweele. Phase: PHASE2. Conditions: Autism Spectrum Disorder, Challenging Behaviour, Aggression, Severe Disruptive Behaviour Disorders, Self-injury

full page →ctgov ↗

COMPLETEDphase readoutNCT02810496: Mutations of Glucocorticoid Receptor in Bilateral Adrenal Hyperplasia

Sponsor: CHU de Reims. Phase: NA. Conditions: General Glucocorticoid Resistance

full page →ctgov ↗

RECRUITINGphase readoutNCT07448246: Effect of Bilateral Rhomboid Intercostal Block on Postoperative Pain After Breast Implant Surgery

Sponsor: Aydin Adnan Menderes University. Phase: NA. Conditions: Breast Prosthesis; Pain, Postoperative Pain, Breast Augmentation

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07717203: Feasibility and Efficacy of Bone Marrow PRP Injection in Refractory Fissure Tendinopathies of the Lateral Epicondylar Tendons

Sponsor: Clinique du Sport, Bordeaux Mérignac. Phase: NA. Conditions: Epicondylitis, Lateral

full page →ctgov ↗

COMPLETEDphase readoutNCT07103603: MHT and Liver Function in Postmenopausal Women

Sponsor: Ipek B. Ozcivit Erkan, MD. Phase: NA. Conditions: Menopause, Non Alcholic Fatty Liver Disease, Hepatic Steatosis

full page →ctgov ↗

COMPLETEDphase readoutNCT07466342: Vitamin E Plus Mefenamic Acid Versus Mefenamic Acid Alone for Treating Primary Dysmenorrhea in Women

Sponsor: Nishtar Medical University. Phase: PHASE4. Conditions: Dysmenorrhea Primary, Vitamin E, Mefenamic Acid

full page →ctgov ↗

RECRUITINGphase readoutNCT07424586: Improving Outcomes of Older Adults Undergoing Ostomy Surgery

Sponsor: Massachusetts General Hospital. Phase: EARLY_PHASE1. Conditions: Ostomy - Ileostomy or Colostomy

full page →ctgov ↗

COMPLETEDphase readoutNCT06235086: A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus

Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.. Phase: PHASE3. Conditions: Type 2 Diabetes Mellitus

full page →ctgov ↗

COMPLETEDphase readoutNCT06099886: Repurposing Lithium for Parkinson's Disease

Sponsor: State University of New York at Buffalo. Phase: PHASE1. Conditions: Parkinson's Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT01804686: A Long-term Extension Study of PCI-32765 (Ibrutinib)

Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B-cell Lymphoma, Waldenstrom Macroglobulinemia, Chronic Graft Versus Host Disease

full page →ctgov ↗

RECRUITINGphase readoutNCT04045470: A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma

Sponsor: Dana-Farber Cancer Institute. Phase: NA. Conditions: Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma

full page →ctgov ↗

COMPLETEDphase readoutNCT07502469: Study Comparing the Contribution of G-Eye Combined With CAD-Eye Versus High-definition Colonoscopy With CAD-Eye in the Detection of Colonic Lesions After a Positive Immunological Test in the Context of Organized Colorectal Cancer (BENEFIT)

Sponsor: Elsan. Phase: . Conditions: Colorectal Cancer, Colo-rectal Cancer

full page →ctgov ↗

ENROLLING_BY_INVITATIONphase readoutNCT07490483: Occlusal Contact Registration Using Jaw Tracking Device Versus Articulating Paper at Different Head Positions

Sponsor: Cairo University. Phase: NA. Conditions: Healthy Adult, Between 20-25 Years Old

full page →ctgov ↗

RECRUITINGphase readoutNCT07584083: Anifrolumab in Adults With Primary Antiphospholipid Syndrome (AnifAPS Trial)

Sponsor: National and Kapodistrian University of Athens. Phase: PHASE2. Conditions: Antiphospholipid Syndrome (APS)

full page →ctgov ↗

COMPLETEDphase readoutNCT03504241: Tolerance by Engaging Antigen During Cellular Homeostasis

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Kidney Transplantation, Renal Transplantation, Renal Transplant Recipient

full page →ctgov ↗

RECRUITINGphase readoutNCT06492954: Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma

Sponsor: Emory University. Phase: PHASE1. Conditions: Osteosarcoma, Pulmonary Recurrence of Osteosarcoma

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07418554: Sleep Disturbances in Children and Adolescents With Post-traumatic Stress Disorder (PTSD): a Randomized Double-blind Placebo-controlled Trial to Investigate the Efficacy of Pediatric Prolonged-release Melatonin

Sponsor: University Hospital, Strasbourg, France. Phase: PHASE3. Conditions: Post-traumatic Stress Disorder (PTSD), Current Significant Sleep Disturbances

full page →ctgov ↗

COMPLETEDphase readoutNCT06744205: A Study on the Safety and Immunogenicity of Hexavalent Influenza mRNA Vaccine in Adult Participants 50 Years of Age and Older

Sponsor: Sanofi Pasteur, a Sanofi Company. Phase: PHASE1. Conditions: Influenza, Healthy Volunteers

full page →ctgov ↗

RECRUITINGphase readoutNCT07043894: Romiplostim N01 for Chemotherapy-Induced Thrombocytopenia in Pediatric Cancer Patients

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Phase: PHASE2. Conditions: Solid Tumors, Hematological Tumor, Children, Adolescent, Chemotherapy Induced Thrombocytopenia

full page →ctgov ↗

COMPLETEDphase readoutNCT06540794: Evaluating Respiratory Effects of Driving Pressure Guided Mechanical Ventilation Using Electrical Impedance Tomography in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy

Sponsor: Istanbul University. Phase: NA. Conditions: Prostate Cancer, Lung Protective Ventilation, Postoperative Pulmonary Complications

full page →ctgov ↗

ACTIVE_NOT_RECRUITINGphase readoutNCT04439266: Testing Crizotinib as a Potential Targeted Treatment in Cancers With ALK Genetic Changes (MATCH-Subprotocol F)

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, Refractory Lymphoma, Refractory Malignant Solid Neoplasm, Refractory Multiple Myeloma

full page →ctgov ↗

RECRUITINGphase readoutNCT05770622: Improving Therapeutic Drug Monitoring and Dosing for Vancomycin in Young Infants With Infections (VANCAPP) (Part 2)

Sponsor: Murdoch Childrens Research Institute. Phase: PHASE4. Conditions: Sepsis, Infections, Bacteremia

full page →ctgov ↗

NOT_YET_RECRUITINGphase readoutNCT07694622: Targeting MYC in High-Risk Medulloblastoma

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS. Phase: NA. Conditions: Medulloblastoma

full page →ctgov ↗

Date TBD